You are here: Industry Insights > Spectrum Pharmaceuticals

News List

Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib Drugs
December 08, 2021
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it has submitted its New Drug Application (NDA) for poziotinib...
Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio firstwordpharma
March 03, 2019
Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today completed the sale of its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma L.L.C., a s
Deals this week: BioMarin Pharmaceutical, Spectrum Pharmaceuticals, Orient Pharma pharmaceutical-technology
August 11, 2017
US-based biotechnology company BioMarin Pharmaceutical has announced the completion of an underwritten public offering of senior subordinated convertible notes to raise $450m.